Search research articles
Contact Us
Filters
Showing results (161-170 of 174) with videos related to
Page
of 18
Sort By:
European Urology Focus
|
February 12, 2018
A New Model to Predict Benign Histology in Residual Retroperitoneal Masses After Chemotherapy in Nonseminoma
Ricardo Leão, Madhur Nayan, Nahid Punjani, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada
|
May 21, 2020
A Canadian approach to the regionalization of testis cancer: A review
Gregory J Nason, Lori A Wood, Robert A Huddart, et al.
International Journal of Radiation Oncology, Biology, Physics
|
February 18, 2004
A multinational, randomized phase III trial of iseganan HCl oral solution for reducing the severity of oral mucositis in patients receiving radiotherapy for head-and-neck malignancy
Andy Trotti, Adam Garden, Padraig Warde, et al.
European Urology Oncology
|
December 8, 2020
Utility of Serum miR-371a-3p in Predicting Relapse on Surveillance in Patients with Clinical Stage I Testicular Germ Cell Cancer
João Lobo, Ricardo Leão, Ad J M Gillis, et al.
International Journal of Radiation Oncology, Biology, Physics
|
August 28, 2022
Extended Results and Independent Validation of a Phase 2 Trial of Metastasis-Directed Therapy for Molecularly Defined Oligometastatic Prostate Cancer
Rachel M Glicksman, Matthew Ramotar, Ur Metser, et al.
International Journal of Radiation Oncology, Biology, Physics
|
November 25, 2025
Stereotactic Body Radiation Therapy for Renal Tumors: A Prospective Phase 2 Clinical Trial
Rachel M Glicksman, Jeff Winter, Andrew McPartlin, et al.
The New England Journal of Medicine
|
August 31, 2012
Intermittent androgen suppression for rising PSA level after radiotherapy
Juanita M Crook, Christopher J O'Callaghan, Graeme Duncan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 15, 2017
Propensity Score Analysis of Radical Cystectomy Versus Bladder-Sparing Trimodal Therapy in the Setting of a Multidisciplinary Bladder Cancer Clinic
Girish S Kulkarni, Thomas Hermanns, Yanliang Wei, et al.
European Urology
|
March 9, 2021
Curative-intent Metastasis-directed Therapies for Molecularly-defined Oligorecurrent Prostate Cancer: A Prospective Phase II Trial Testing the Oligometastasis Hypothesis
Rachel M Glicksman, Ur Metser, Douglass Vines, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 16, 2017
Randomized Trial of a Hypofractionated Radiation Regimen for the Treatment of Localized Prostate Cancer
Charles N Catton, Himu Lukka, Chu-Shu Gu, et al.
Page
of 18
Search research articles
Search
Showing results (161-170 of 174) with videos related to
Sort By:
Page
of 18
European Urology Focus
|
February 12, 2018
A New Model to Predict Benign Histology in Residual Retroperitoneal Masses After Chemotherapy in Nonseminoma
Ricardo Leão, Madhur Nayan, Nahid Punjani, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada
|
May 21, 2020
A Canadian approach to the regionalization of testis cancer: A review
Gregory J Nason, Lori A Wood, Robert A Huddart, et al.
International Journal of Radiation Oncology, Biology, Physics
|
February 18, 2004
A multinational, randomized phase III trial of iseganan HCl oral solution for reducing the severity of oral mucositis in patients receiving radiotherapy for head-and-neck malignancy
Andy Trotti, Adam Garden, Padraig Warde, et al.
European Urology Oncology
|
December 8, 2020
Utility of Serum miR-371a-3p in Predicting Relapse on Surveillance in Patients with Clinical Stage I Testicular Germ Cell Cancer
João Lobo, Ricardo Leão, Ad J M Gillis, et al.
International Journal of Radiation Oncology, Biology, Physics
|
August 28, 2022
Extended Results and Independent Validation of a Phase 2 Trial of Metastasis-Directed Therapy for Molecularly Defined Oligometastatic Prostate Cancer
Rachel M Glicksman, Matthew Ramotar, Ur Metser, et al.
International Journal of Radiation Oncology, Biology, Physics
|
November 25, 2025
Stereotactic Body Radiation Therapy for Renal Tumors: A Prospective Phase 2 Clinical Trial
Rachel M Glicksman, Jeff Winter, Andrew McPartlin, et al.
The New England Journal of Medicine
|
August 31, 2012
Intermittent androgen suppression for rising PSA level after radiotherapy
Juanita M Crook, Christopher J O'Callaghan, Graeme Duncan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 15, 2017
Propensity Score Analysis of Radical Cystectomy Versus Bladder-Sparing Trimodal Therapy in the Setting of a Multidisciplinary Bladder Cancer Clinic
Girish S Kulkarni, Thomas Hermanns, Yanliang Wei, et al.
European Urology
|
March 9, 2021
Curative-intent Metastasis-directed Therapies for Molecularly-defined Oligorecurrent Prostate Cancer: A Prospective Phase II Trial Testing the Oligometastasis Hypothesis
Rachel M Glicksman, Ur Metser, Douglass Vines, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 16, 2017
Randomized Trial of a Hypofractionated Radiation Regimen for the Treatment of Localized Prostate Cancer
Charles N Catton, Himu Lukka, Chu-Shu Gu, et al.
Page
of 18